NL7306806A - - Google Patents

Info

Publication number
NL7306806A
NL7306806A NL7306806A NL7306806A NL7306806A NL 7306806 A NL7306806 A NL 7306806A NL 7306806 A NL7306806 A NL 7306806A NL 7306806 A NL7306806 A NL 7306806A NL 7306806 A NL7306806 A NL 7306806A
Authority
NL
Netherlands
Application number
NL7306806A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7306806A publication Critical patent/NL7306806A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Golf Clubs (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NL7306806A 1972-05-17 1973-05-16 NL7306806A (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00254148A US3803115A (en) 1972-05-17 1972-05-17 Stabilization of ahf using heparin

Publications (1)

Publication Number Publication Date
NL7306806A true NL7306806A (enrdf_load_stackoverflow) 1973-11-20

Family

ID=22963114

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7306806A NL7306806A (enrdf_load_stackoverflow) 1972-05-17 1973-05-16

Country Status (18)

Country Link
US (2) US3803115A (enrdf_load_stackoverflow)
JP (1) JPS596845B2 (enrdf_load_stackoverflow)
AT (1) AT344881B (enrdf_load_stackoverflow)
AU (1) AU465351B2 (enrdf_load_stackoverflow)
BE (1) BE799525A (enrdf_load_stackoverflow)
CA (1) CA1007986A (enrdf_load_stackoverflow)
CH (1) CH630804A5 (enrdf_load_stackoverflow)
DE (1) DE2324717C3 (enrdf_load_stackoverflow)
DK (1) DK136016B (enrdf_load_stackoverflow)
ES (1) ES414823A1 (enrdf_load_stackoverflow)
FR (1) FR2184898B1 (enrdf_load_stackoverflow)
GB (1) GB1372515A (enrdf_load_stackoverflow)
IL (1) IL42221A (enrdf_load_stackoverflow)
IT (1) IT1061433B (enrdf_load_stackoverflow)
NL (1) NL7306806A (enrdf_load_stackoverflow)
NO (1) NO142381C (enrdf_load_stackoverflow)
SE (1) SE430020B (enrdf_load_stackoverflow)
ZA (1) ZA733138B (enrdf_load_stackoverflow)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4089944A (en) 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
DE3163003D1 (en) * 1980-01-18 1984-05-17 Canadian Red Cross Method of obtaining factor viii
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
US4397841A (en) 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4710381A (en) 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
ATE73820T1 (de) * 1986-03-27 1992-04-15 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
EP1363616A1 (en) * 2001-02-07 2003-11-26 Shanbrom Technologies, LLC Carboxylic acid such as citric acid for disinfecting or enhancing the production of blood products such as plasma, cryoprecipitate or/and platelet

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
DE1949314U (de) 1966-05-07 1966-11-10 Braun Fa B Bohrdraht-bereitschaftskasten.
BE713764A (enrdf_load_stackoverflow) 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol

Also Published As

Publication number Publication date
NO142381B (no) 1980-05-05
NO142381C (no) 1980-08-13
GB1372515A (en) 1974-10-30
ZA733138B (en) 1974-03-27
FR2184898A1 (enrdf_load_stackoverflow) 1973-12-28
DE2324717B2 (de) 1980-01-03
BE799525A (fr) 1973-08-31
AU465351B2 (en) 1975-09-25
IT1061433B (it) 1983-02-28
JPS596845B2 (ja) 1984-02-15
ES414823A1 (es) 1976-02-01
JPS4956695A (enrdf_load_stackoverflow) 1974-06-01
DE2324717C3 (de) 1983-12-01
DK136016C (enrdf_load_stackoverflow) 1978-01-02
AU5584973A (en) 1974-11-21
US3803115A (en) 1974-04-09
IL42221A0 (en) 1973-07-30
IL42221A (en) 1977-04-29
CH630804A5 (de) 1982-07-15
AT344881B (de) 1978-08-10
DE2324717A1 (de) 1973-12-13
SE430020B (sv) 1983-10-17
CA1007986A (en) 1977-04-05
USRE29698E (en) 1978-07-11
ATA433573A (de) 1975-04-15
DK136016B (da) 1977-08-01
FR2184898B1 (enrdf_load_stackoverflow) 1976-11-05

Similar Documents

Publication Publication Date Title
FR2184898B1 (enrdf_load_stackoverflow)
CS161678B2 (enrdf_load_stackoverflow)
CS161674B2 (enrdf_load_stackoverflow)
CS159447B1 (enrdf_load_stackoverflow)
CS158484B1 (enrdf_load_stackoverflow)
CS159014B1 (enrdf_load_stackoverflow)
CS158509B1 (enrdf_load_stackoverflow)
CS161313B1 (enrdf_load_stackoverflow)
CS160370B1 (enrdf_load_stackoverflow)
CS159514B1 (enrdf_load_stackoverflow)
CS161466B1 (enrdf_load_stackoverflow)
CS161343B1 (enrdf_load_stackoverflow)
CS159020B1 (enrdf_load_stackoverflow)
CS161352B1 (enrdf_load_stackoverflow)
CS162175B1 (enrdf_load_stackoverflow)
CS154547B1 (enrdf_load_stackoverflow)
CS157599B1 (enrdf_load_stackoverflow)
CS157592B1 (enrdf_load_stackoverflow)
CS157565B1 (enrdf_load_stackoverflow)
CS155576B1 (enrdf_load_stackoverflow)
CS154548B1 (enrdf_load_stackoverflow)
CH565234A5 (enrdf_load_stackoverflow)
CH566411A5 (enrdf_load_stackoverflow)
CH581492A5 (enrdf_load_stackoverflow)
CH582754A5 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed